4-(4,6-Dichloropyrimidin-2-yl)morpholine → 1-(4-(6-Chloro-2-morpholinopyrimidin-4-yl)phenyl)-3-ethylurea
Reaction equation
[Cl:1][C:2]1[N:7]=[C:6]([N:8]2[CH2:13][CH2:12][O:11][CH2:10][C@@H:9]2C)[N:5]=[C:4]([C:15]2[CH:20]=[CH:19][C:18]([NH:21][C:22]([NH:24][CH2:25][CH3:26])=[O:23])=[CH:17][CH:16]=2)[CH:3]=1.ClC1C=C(Cl)N=C(N2CCOCC2)N=1>>[Cl:1][C:2]1[N:7]=[C:6]([N:8]2[CH2:9][CH2:10][O:11][CH2:12][CH2:13]2)[N:5]=[C:4]([C:15]2[CH:16]=[CH:17][C:18]([NH:21][C:22]([NH:24][CH2:25][CH3:26])=[O:23])=[CH:19][CH:20]=2)[CH:3]=1Participants
3
Procedure
Method as described for Intermediate 2 using 4-(4,6-dichloropyrimidin-2-yl)morpholine.
Sources & evidence
- ORD record
- ord-78be874bfe2f4afb901cf5dbd6f535c8
- Source dataset
- uspto-grants-2016_02
- Patent number
- US09249129B2
Reaction notes
Loading…